V015-6350 Screening compound: 3-[4-(dimethylamino)phenyl]-1-(2,3-dimethylphenyl)-4-[4-(3-fluorobenzamido)phenyl]-1H-pyrazol-5-yl acetate

V015-6350 Screening compound: 3-[4-(dimethylamino)phenyl]-1-(2,3-dimethylphenyl)-4-[4-(3-fluorobenzamido)phenyl]-1H-pyrazol-5-yl acetate
V015-6350 Screening compound: 3-[4-(dimethylamino)phenyl]-1-(2,3-dimethylphenyl)-4-[4-(3-fluorobenzamido)phenyl]-1H-pyrazol-5-yl acetate alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-6350
3-[4-(dimethylamino)phenyl]-1-(2,3-dimethylphenyl)-4-[4-(3-fluorobenzamido)phenyl]-1H-pyrazol-5-yl acetate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-6350

Molecular Formula

C34H31FN4O3 (C34 H31 FN4 O3)

Compound Name

3-[4-(dimethylamino)phenyl]-1-(2,3-dimethylphenyl)-4-[4-(3-fluorobenzamido)phenyl]-1H-pyrazol-5-yl acetate

IUPAC name

3-[4-(dimethylamino)phenyl]-1-(23-dimethylphenyl)-4-[4-(3-fluorobenzamido)phenyl]-1H-pyrazol-5-yl acetate

SMILES

CC(Oc(n(-c1c(C)c(C)ccc1)nc1-c(cc2)ccc2N(C)C)c1-c(cc1)ccc1NC(c1cccc(F)c1)=O)=O

InChI

InChI=1S/C34H31FN4O3/c1-21-8-6-11-30(22(21)2)39-34(42-23(3)40)31(32(37-39)25-14-18-29(19-15-25)38(4)5)24-12-16-28(17-13-24)36-33(41)26-9-7-10-27(35)20-26/h6-20H,1-5H3,(H,36,41)

InChI Key

IMXOOBZNMXTSSP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19868881

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

562.64

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

7.198

Distribution Coefficient, logD

7.198

Water Solubility, LogSw

-5.80

Polar Surface Area

60.169

Acid Dissociation Constant (pKa)

10.51

Base Dissociation Constant (pKb)

7.98

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

14.70

V015-6350 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

MCL1 Targeted Library (12200 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with V015-6350 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-6350?
Check Price and Availability of V015-6350, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-6350 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-6350
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-6350
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-6350 available by request